Vertex Pharmaceuticals – VCGT
316-318 North Avenue, Boston MA
About the project
Vertex was looking to expand their cell and gene therapy labs and hired Hereva to provide senior level project management oversight to ensure that Vertex’s feel/culture/branding requirements were adhered to despite an accelerated time frame. Since this is a new, ground-up building and Hereva, in addition to the PM and cost management work, was hired to help coordinate the tenant fit up with the landlord’s core and shell construction.
This poses many challenges with MEP coordination and scheduling. Originally the multi-story building was intended for multiple tenants, but Vertex signed the full building lease which means significant changes to core and shell MEP design.
The new facility will house research and development labs, clinical-scale manufacturing operations, analytical and microbiology labs, general office space, support operations such as waste stream management, loading dock, bulk gas storage, and staff amenities, and retail space.
This design is intended to be a state-of-the-art facility, with the manufacturing operations meeting specified cGMP requirements and ISO classifications and is committed to achieving LEED Silver certification or better. GMP support operations will include a cGMP warehouse with cold storage, QC raw materials sampling, and QC analytical and microbiological labs. The building shell and core (S&C) will be delivered with MEP systems sized for a 60% lab and 40% office facility, plus back up power and other standard lab building provisions.
The office space fit-out will be a modern agile/open workspace designed with innovation & collaborative areas. Recently completed and current workspace projects at other Vertex facilities will have a strong influence on the form, fit and function of the facility.
The project is on target to achieve LEED Platinum.
About the Client
Vertex is a global biotechnology company that aims to discover, develop and commercialize innovative medicines so people with serious diseases can lead better lives. In addition to their clinical development programs focused on cystic fibrosis, Vertex has more than a dozen ongoing research programs aimed at other serious and life-threatening diseases.